(Q44294087)

1 December 2017

title

Enhanced complement-susceptibility and dysfunction of lymphocytes in paroxysmal nocturnal haemoglobinuria (PNH). (English)

1 reference

1 December 2017

Tomiyama J

1

1 reference

1 December 2017

Ninomiya H

series ordinal

2

1 reference

1 December 2017

Abe T

series ordinal

3

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 December 1990

1 reference

British Journal of Haematology

1 December 2017

published in

1 reference

1 December 2017

volume

76

1 reference

1 December 2017

issue

4

1 reference

1 December 2017

page(s)

540-544

1 reference

Immunologic dysfunction in the myeloproliferative disorders

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1990.TB07913.X

The mechanism of action of decay-accelerating factor (DAF). DAF inhibits the assembly of C3 convertases by dissociating C2a and Bb

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1990.TB07913.X

Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1990.TB07913.X

Cytolysis of nucleated cells by complement: cell death displays multi-hit characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1990.TB07913.X

Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1990.TB07913.X

10.1111/J.1365-2141.1990.TB07913.X

21 January 2018

Identifiers

DOI

1 reference

1 December 2017

1 reference